A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. 2005

Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
Clinical Research Group OE 6711, Medical Research School Hannover, Germany.

The Liverpool epidemic strain (LES) of Pseudomonas aeruginosa is a transmissible aggressive pathogen of cystic fibrosis (CF) patients. We compared transcriptome profiles of two LES isolates with each other and with a laboratory and genetic reference strain (PAO1) after growth to late exponential phase and following exposure to oxidative stress. Both LES isolates exhibited enhanced antimicrobial resistances linked to specific mutations in efflux pump genes. Although transcription of AmpC beta-lactamase was up-regulated in both, one LES isolate contained a specific mutation rendering the ampC gene untranslatable. The virulence-related quorum-sensing (QS) regulon of LES431, an isolate that caused pneumonia in the non-CF parent of a CF patient, was considerably up-regulated in comparison to either isolate LES400, associated with a chronic CF infection, or strain PAO1. Premature activation of QS genes was detected in isolates from both non-CF parents and the CF patient in a previously reported infection episode. LES isolates lacking the up-regulated QS phenotype contained different frameshift mutations in lasR. When fed to Drosophila melanogaster, isolate LES431 killed the fruit flies more readily than either isolate LES400 or strain PAO1, indicating that virulence varies intraclonally. The LES may represent a clone with enhanced virulence and antimicrobial resistance characteristics that can vary or are lost due to mutations during long-term colonization but have contributed to the successful spread of the lineage throughout the CF population of the United Kingdom.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004798 Enzymes Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified. Biocatalyst,Enzyme,Biocatalysts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases
D012329 RNA, Bacterial Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis. Bacterial RNA

Related Publications

Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
September 2010, The Journal of infectious diseases,
Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
January 2003, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology,
Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
March 2014, The Journal of infectious diseases,
Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
November 2018, Pediatric pulmonology,
Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
May 2005, American journal of respiratory and critical care medicine,
Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
March 2021, The Journal of antimicrobial chemotherapy,
Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
September 2008, Thorax,
Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
January 2011, Antimicrobial agents and chemotherapy,
Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
August 2006, Journal of medical microbiology,
Prabhakar Salunkhe, and Catherine H M Smart, and J Alun W Morgan, and Stavroula Panagea, and Martin J Walshaw, and C Anthony Hart, and Robert Geffers, and Burkhard Tümmler, and Craig Winstanley
March 2009, FEMS microbiology letters,
Copied contents to your clipboard!